Form 8-K · Current report
ON Semiconductor 8-K, filed Aug 13, 2026
- Filed
- CIK
- 0001097864
- Accession no.
- 0001140361-26-032594
Summary
ON Semiconductor said the U.S. Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period for its pending acquisition of Synaptics, under which a wholly owned onsemi subsidiary would merge into Synaptics and Synaptics would survive as a wholly owned onsemi subsidiary. The deal, announced June 25, 2026, remains subject to Synaptics stockholder approval and other regulatory clearances, with the parties continuing to expect closing in mid-2027.
Key points
- ON Semiconductor entered a merger agreement with Synaptics on June 25, 2026, with merger subsidiary Sonic Acquisition Corp. merging into Synaptics.
- The companies filed their Hart-Scott-Rodino notifications on July 17, 2026.
- The FTC granted early termination of the HSR waiting period on August 12, 2026.
- Closing remains subject to Synaptics stockholder approval and certain other regulatory approvals or clearances.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01 Other Events. As previously announced, on June 25, 2026, ON Semiconductor Corporation (“onsemi”) entered into an Agreement and Plan of Reorganization (the “Merger Agreement”) with Sonic Acquisition Corp., a Delaware corporation and wholly owned subsidiary of onsemi (“Merger Sub”), and Synaptics Incorporated, a Delaware corporation (“Synaptics”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, Merger Sub will merge with and into Synaptics (the “Merger”), with Synaptics surviving the Merger as a wholly owned subsidiary of onsemi. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.